Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1994 Jan; 38(1): 1–6.
PMCID: PMC284388

Central nervous system-immune system interactions: psychoneuroendocrinology of stress and its immune consequences.


Psychoneuroimmunology is a relatively new discipline which deals with CNS-immune system interactions. The evidence for such interactions was reviewed, as was the neuroendocrinologic response to stress. Recent evidence indicates that the behavioral, nervous system, and neuroendocrine responses to stress are mediated by hypothalamic CRF, which acts on both the sympathetic nervous system and the HPA axis, resulting in increased levels of corticosteroids, catecholamines, and certain opiates, substances which are generally immunosuppressive. Concentrations of growth hormone and prolactin, which are immunoenhancing, are elevated early during the response to stress but are later suppressed. Although several other neuromediators may also be released with stress, the net effect of a variety of acute stressors is down regulation of the immune system function. In the following minireview, I consider whether stress alters the resistance of the host to infection as well as the immunomodulatory effects of released immune system mediators on the brain.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ader R, Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med. 1975 Jul-Aug;37(4):333–340. [PubMed]
  • Arnason BG. Nervous system-immune system communication. Rev Infect Dis. 1991 Jan-Feb;13 (Suppl 1):S134–S137. [PubMed]
  • Baroni C. Thymus, peripheral lymphoid tissues and immunological responsiveness of the pituitary dwarf mouse. Experientia. 1967 Apr 15;23(4):282–283. [PubMed]
  • Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science. 1988 Jan 22;239(4838):401–404. [PubMed]
  • Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 1989 Jan;69(1):1–32. [PubMed]
  • Brummitt CF, Sharp BM, Gekker G, Keane WF, Peterson PK. Modulatory effects of beta-endorphin on interferon-gamma production by cultured peripheral blood mononuclear cells: heterogeneity among donors and the influence of culture medium. Brain Behav Immun. 1988 Sep;2(3):187–197. [PubMed]
  • Chelmicka-Schorr E, Arnason BG. Nervous system-immune system interactions. Res Publ Assoc Res Nerv Ment Dis. 1990;68:67–90. [PubMed]
  • Chelmicka-Schorr E, Kwasniewski MN, Thomas BE, Arnason BG. The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol. 1989 Dec;25(2-3):203–207. [PubMed]
  • Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992 Mar 4;267(9):1244–1252. [PubMed]
  • Clevenger CV, Russell DH, Appasamy PM, Prystowsky MB. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6460–6464. [PMC free article] [PubMed]
  • Dantzer R, Kelley KW. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 1989;44(26):1995–2008. [PubMed]
  • Dardenne M, Kelly PA, Bach JF, Savino W. Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9700–9704. [PMC free article] [PubMed]
  • Dunn AJ, Berridge CW. Is corticotropin-releasing factor a mediator of stress responses? Ann N Y Acad Sci. 1990;579:183–191. [PubMed]
  • Edwards CK, 3rd, Yunger LM, Lorence RM, Dantzer R, Kelley KW. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2274–2277. [PMC free article] [PubMed]
  • Felten DL, Felten SY. Sympathetic noradrenergic innervation of immune organs. Brain Behav Immun. 1988 Dec;2(4):293–300. [PubMed]
  • Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA, Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev. 1987 Dec;100:225–260. [PubMed]
  • Fiatarone MA, Morley JE, Bloom ET, Benton D, Makinodan T, Solomon GF. Endogenous opioids and the exercise-induced augmentation of natural killer cell activity. J Lab Clin Med. 1988 Nov;112(5):544–552. [PubMed]
  • Irwin M, Hauger RL, Jones L, Provencio M, Britton KT. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther. 1990 Oct;255(1):101–107. [PubMed]
  • Janković BD. Neuroimmunomodulation: facts and dilemmas. Immunol Lett. 1989 May;21(2):101–118. [PubMed]
  • Kelley KW. Cross-talk between the immune and endocrine systems. J Anim Sci. 1988 Aug;66(8):2095–2108. [PubMed]
  • Kelley KW. Growth hormone, lymphocytes and macrophages. Biochem Pharmacol. 1989 Mar 1;38(5):705–713. [PubMed]
  • Khansari DN, Murgo AJ, Faith RE. Effects of stress on the immune system. Immunol Today. 1990 May;11(5):170–175. [PubMed]
  • Kiecolt-Glaser JK, Cacioppo JT, Malarkey WB, Glaser R. Acute psychological stressors and short-term immune changes: what, why, for whom, and to what extent? Psychosom Med. 1992 Nov-Dec;54(6):680–685. [PubMed]
  • Lightman SL, Young WS., 3rd Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4306–4310. [PMC free article] [PubMed]
  • Melia KR, Duman RS. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8382–8386. [PMC free article] [PubMed]
  • Millar DB, Hough CJ, Mazorow DL, Gootenberg JE. Beta-endorphin's modulation of lymphocyte proliferation is dose, donor, and time dependent. Brain Behav Immun. 1990 Sep;4(3):232–242. [PubMed]
  • Munck A, Guyre PM. Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol. 1986;196:81–96. [PubMed]
  • Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984 Winter;5(1):25–44. [PubMed]
  • Nordlind K, Mutt V, Sundström E. Effect of neuropeptides and monoamines on lymphocyte activation. Brain Behav Immun. 1988 Dec;2(4):282–292. [PubMed]
  • Peterson PK, Chao CC, Molitor T, Murtaugh M, Strgar F, Sharp BM. Stress and pathogenesis of infectious disease. Rev Infect Dis. 1991 Jul-Aug;13(4):710–720. [PubMed]
  • Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF. Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest. 1987 Sep;80(3):824–831. [PMC free article] [PubMed]
  • Prieto J, Subirá ML, Castilla A, Arroyo JL, Serrano M. Opioid peptides modulate the organization of vimentin filaments, phagocytic activity, and expression of surface molecules in monocytes. Scand J Immunol. 1989 Apr;29(4):391–398. [PubMed]
  • Rogers TJ, Taub DD, Eisenstein TK, Geller EB, Adler MW. Immunomodulatory activity of kappa-, mu-, and delta-selective opioid compounds. NIDA Res Monogr. 1990;105:82–88. [PubMed]
  • Sapolsky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology. 1985 Aug;117(2):662–666. [PubMed]
  • Savino W, Gagnerault MC, Bach JF, Dardenne M. Neuroendocrine control of thymic hormonal production. II. Stimulatory effects of endogenous opioids on thymulin production by cultured human and murine thymic epithelial cells. Life Sci. 1990;46(23):1687–1697. [PubMed]
  • Solomon GF, Amkraut AA. Psychoneuroendocrinological effects on the immune response. Annu Rev Microbiol. 1981;35:155–184. [PubMed]
  • Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2046–2050. [PMC free article] [PubMed]
  • Tsagarakis S, Holly JM, Rees LH, Besser GM, Grossman A. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Endocrinology. 1988 Oct;123(4):1962–1969. [PubMed]
  • Valentino RJ. CRH effects on central noradrenergic neurons: relationship to stress. Adv Exp Med Biol. 1988;245:47–64. [PubMed]
  • Valentino RJ. Corticotropin-releasing factor: putative neurotransmitter in the noradrenergic nucleus locus ceruleus. Psychopharmacol Bull. 1989;25(3):306–311. [PubMed]
  • Wiedemann K, von Bardeleben U, Holsboer F. Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion. Neuroendocrinology. 1991 Nov;54(5):462–468. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...